Levodopa-related wearing-off in Parkinson's disease: identification and management
about
Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease modelsEfficacy and safety of Tai Chi for Parkinson's disease: a systematic review and meta-analysis of randomized controlled trialsAging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's DiseaseAsian perspectives on the recognition and management of levodopa 'wearing-off' in Parkinson's disease.Parkinson's Disease and Its Management: Part 4: Treatment of Motor ComplicationsTreatment strategies for Parkinson's disease.Parkinson's Disease: From Pathogenesis to PharmacogenomicsOptimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone.Clinical Presentation of Anxiety in Parkinson's Disease: A Scoping Review.Non-human primate models of PD to test novel therapies.Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA.L-Dopa and Brain Serotonin System Dysfunction.Rasagiline for dysexecutive symptoms during wearing-off in Parkinson's disease: a pilot study.The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson's disease.In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease.Motor Complications of Dopaminergic Medications in Parkinson's Disease.Clinimetrics of the 9- and 19-Item Wearing-Off Questionnaire: A Systematic Review.
P2860
Q26775886-33587A13-48FF-4117-9445-E72149859739Q33753491-5580CDCA-B2FC-4D4E-8A20-5D6AC2EA6D6CQ33920647-7A4362F0-FD4E-42F3-8F65-A76AE051FB53Q35781883-C77DE883-A1B3-4693-BBE5-0321012AED83Q36251899-1AFF24E4-4D88-4537-ADF9-6482ADB22182Q37681312-BA896110-DCE9-422C-8F90-9B4F1634C20BQ37729129-995C2F4E-1659-4554-BF13-DF80DA5AD6B3Q37979869-6EDF7983-6FF6-4623-8A7D-12D28E05C99BQ38952143-76C7981B-3060-4CDF-919D-526B616586D7Q39229450-E7FA4F1A-1AEF-40F0-AD04-6AE506879C37Q39350609-CA924208-FBB6-4C3C-B928-6DF3B1BFE46EQ47112234-D8916686-3D27-426E-9185-D7DBA4350A61Q48278386-00094A09-2B5E-4F46-B57D-F5125C67389EQ50547059-48171AA1-C7AE-48BC-A5C4-C45BD2D199C2Q51442945-CA480327-DF60-4DDA-98FD-20437BDF603DQ52665081-54599EFF-9711-4339-BE53-AF54EE70FC23Q55279095-82C074E3-4B1C-4A2B-A881-8F84536AC2A3Q55286065-ECD71BD1-61CF-4ECF-A4E0-5B39C8AF66D3
P2860
Levodopa-related wearing-off in Parkinson's disease: identification and management
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Levodopa-related wearing-off in Parkinson's disease: identification and management
@ast
Levodopa-related wearing-off in Parkinson's disease: identification and management
@en
Levodopa-related wearing-off in Parkinson's disease: identification and management
@nl
type
label
Levodopa-related wearing-off in Parkinson's disease: identification and management
@ast
Levodopa-related wearing-off in Parkinson's disease: identification and management
@en
Levodopa-related wearing-off in Parkinson's disease: identification and management
@nl
prefLabel
Levodopa-related wearing-off in Parkinson's disease: identification and management
@ast
Levodopa-related wearing-off in Parkinson's disease: identification and management
@en
Levodopa-related wearing-off in Parkinson's disease: identification and management
@nl
P1476
Levodopa-related wearing-off in Parkinson's disease: identification and management
@en
P2093
Kelly E Lyons
P356
10.1185/03007990902779319
P407
P50
P577
2009-04-01T00:00:00Z